EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice

Qian Wang, Megan P Leask, Kate Lee, Jagdish Jaiswal, Prasanna Kallingappa, Waruni Dissanayake, Chris Puli'uvea, Conor O'Sullivan, Huti Watson, Phillip Wilcox, Rinki Murphy, Troy L Merry und 1 weitere

Diabetologia · 2025

DOI: 10.1007/s00125-024-06287-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2025. Verfasst von Qian Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Metformin, Insulin Resistance, Hypoglycemic Agents, Organic Cation Transport Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Metformin is an important first-line treatment for type 2 diabetes and acts by increasing the body’s ability to dispose of glucose. Metformin’s efficacy can be affected by genetic variants in the transporters that regulate its uptake into cells. The SLC22A3 gene (also known as EMT; EMTH; OCT3 ) codes for organic cation transporter 3 (OCT3), which is a broad-specificity cation transporter that also transports metformin. Most SLC22A3 variants reduce the rate of metformin transport but the rs8187715 variant (p.Thr44Met) is reported to increase uptake of metformin in vitro. However, the impact of this on in vivo metformin transport and efficacy is unknown. Very few carriers of this variant have been reported globally, but, notably, all were of Pacific Island descent. Therefore, this study aims to understand the prevalence of this variant in Polynesian peoples (Māori and Pacific peoples) and to understand its impact on metformin transport and efficacy in vivo. Methods rs8187715 was genotyped in 310 individuals with Māori and Pacific ancestry recruited in Aotearoa New Zealand. To study this variant in a physiological context, an orthologous knockin mouse model with C57BL/6J background was used. Pharmacokinetic analysis compared uptake rate of metformin into tissues. Plasma growth/differentiation factor 15 (GDF-15) was also measured as a marker of metformin efficacy. Glucose and insulin tolerance was assessed after acute or sustained metformin treatment in knockin and wild-type control mice to examine the impact of the variant on metformin’s glycaemic control. Results The minor allele frequency of this variant in the Māori and Pacific participants was 15.4%. There was no association of the variant with common metabolic parameters including diabetes status, BMI, blood pressure, lipids, or blood glucose and HbA 1c . However, in the orthologous knockin mouse model, the rate of metformin uptake into the blood and tissues was increased. Acute metformin dosing increased insulin sensitivity in variant knockin mice but this effect was lost after longer-term metformin treatment. Metformin’s effects on GDF-15 levels were also lost in variant knockin mice with longer-term metformin treatment. Conclusions/interpretation These data provide evidence that the SLC22A3 rs8187715 variant accelerates metformin uptake rate in vivo. While this acutely improves insulin sensitivity, there was no increased effect of metformin with longer-term dosing. Thus, our finding of a high prevalence of this variant specifically in Māori and Pacific peoples identifies it as a potential population-specific pharmacogenetic marker with potential to guide metformin therapy in these peoples. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminInsulin ResistanceHypoglycemic AgentsOrganic Cation Transport ProteinsAnimalsMiceMice, Inbred C57BLHumansMaleDiabetes Mellitus, Type 2FemalePolymorphism, Single NucleotideGenotypeMiddle AgedOrganic Cation Transporter 3

Stichwörter der Autor:innen

SLC22A3DiabetesGDF-15Insulin sensitivityMetforminPharmacogeneticsPrecision medicine

Substanzen

MetforminHypoglycemic AgentsOrganic Cation Transport ProteinsOrganic Cation Transporter 3

Autor:innen und Institutionen

  • Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
  • Maurice Wilkins Centre, Auckland, New Zealand.
  • University of Alabama, Birmingham, AL, USA.
  • Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand.
  • Department of Biomedicine and Diagnostics, Auckland University of Technology, Auckland, New Zealand.
  • Moko Foundation, Kaitaia, New Zealand.

Förderung

  • Health Research Council of New Zealand
  • Maurice Wilkins Centre for Molecular Biodiscovery
  • University of Auckland

Zitieren

APA

Wang, Q., Leask, M. P., Lee, K., Jaiswal, J., Kallingappa, P., Dissanayake, W., Puli'uvea, C., O'Sullivan, C., Watson, H., Wilcox, P., Murphy, R., Merry, T. L., & Shepherd, P. R. (2025). The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice. Diabetologia. https://doi.org/10.1007/s00125-024-06287-1

Vancouver

Wang Q, Leask MP, Lee K, Jaiswal J, Kallingappa P, Dissanayake W, et al. The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice. Diabetologia. 2025. doi:10.1007/s00125-024-06287-1

BibTeX
@article{Wang2025,
  author = {Wang, Qian and Leask, Megan P and Lee, Kate and Jaiswal, Jagdish and Kallingappa, Prasanna and Dissanayake, Waruni and Puli'uvea, Chris and O'Sullivan, Conor and Watson, Huti and Wilcox, Phillip and Murphy, Rinki and Merry, Troy L and Shepherd, Peter R},
  title = {The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice},
  journal = {Diabetologia},
  year = {2025},
  doi = {10.1007/s00125-024-06287-1}
}
Kostenlos starten →